tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Vivos Therapeutics Inc

VVOS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
0.157USD
-0.003-1.88%
์ข…๊ฐ€ย 09-22 16:00๏ผˆET๏ผ‰
2.18M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
์žฅ์ „ ๊ฑฐ๋ž˜ย 07:56ย (ET)0.157USD0.000

Vivos Therapeutics Inc

0.157
-0.003-1.88%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

VVOS ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Vivos Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
2.18M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-0.07
์ฃผ๋‹น์ˆœ์ด์ต
-2.14
์ˆ˜์ต
17.44M
์ˆœ์ด์ต
-11.14M
ROE
-1.53K%
ROA
-138.29%

Vivos Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 14, 2026
EPS / ์˜ˆ์ƒ
-0.31/-0.39
์ˆ˜์ต / ์˜ˆ์ƒ
5.15M/5.37M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
43.81%-0.31
-16.77%-0.52
-41.98%-0.55
-24.55%-0.49
7.72%-0.55
72.43%-0.45
86.97%-0.39
77.38%-0.40
87.05%-0.60
5.17%-1.63
54.65%-3.00
72.68%-1.75
---4.62
---1.72
---6.62
---6.40
----
----
----
----
์ˆ˜์ต
34.90%5.15M
70.46%5.14M
3.41%3.82M
75.73%6.78M
-5.77%3.82M
-11.79%3.02M
13.85%3.70M
16.93%3.86M
19.41%4.05M
-11.36%3.42M
-17.77%3.25M
-22.26%3.30M
-18.86%3.40M
5.85%3.86M
-10.11%3.95M
-6.60%4.25M
-6.96%4.18M
5.69%3.64M
32.88%4.39M
38.11%4.55M
์ˆœ์ด์ต
-9.34%-5.48M
-98.81%-7.68M
-143.86%-6.89M
-106.42%-5.40M
-159.74%-5.01M
-2.68%-3.86M
33.62%-2.83M
-24.99%-2.62M
65.09%-1.93M
-120.96%-3.76M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.70M
17.64%-6.09M
0.35%-5.43M
-72.96%-6.99M
-56.83%-5.33M
-18.30%-7.39M
-200.76%-5.45M
์ˆœ์ด์ต๋ฅ 
18.33%-107.18%
-17.68%-150.77%
-137.88%-181.85%
-17.47%-79.61%
-175.65%-131.23%
-16.40%-128.12%
41.70%-76.45%
-6.89%-67.77%
70.76%-47.61%
-149.27%-110.06%
14.94%-131.13%
50.46%-63.41%
---162.83%
---44.15%
---154.15%
---127.98%
----
----
----
----
์ด ์ด์ต๋ฅ 
0.39%47.41%
14.73%50.67%
26.07%66.58%
-7.59%52.38%
-23.60%47.23%
-15.69%44.16%
-4.12%52.81%
7.04%56.68%
7.62%61.82%
-6.55%52.38%
-1.78%55.08%
-3.13%52.95%
--57.44%
--56.05%
--56.08%
--54.66%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
10.00%34.28%
--31.43%
--35.74%
--34.70%
--31.16%
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
34.90%5.15M
70.46%5.14M
3.41%3.82M
75.73%6.78M
-5.77%3.82M
-11.79%3.02M
13.85%3.70M
16.93%3.86M
19.41%4.05M
-11.36%3.42M
-17.77%3.25M
-22.26%3.30M
-18.86%3.40M
5.85%3.86M
-10.11%3.95M
-6.60%4.25M
-6.96%4.18M
5.69%3.64M
32.88%4.39M
38.11%4.55M
์˜์—… ์ด์ต
0.82%-4.83M
-68.84%-6.62M
-127.44%-6.38M
-78.98%-4.73M
-151.29%-4.87M
-3.51%-3.92M
34.50%-2.81M
24.19%-2.65M
57.14%-1.94M
24.38%-3.79M
29.34%-4.28M
35.47%-3.49M
35.14%-4.52M
24.61%-5.00M
6.73%-6.06M
1.74%-5.41M
-71.47%-6.96M
-94.87%-6.64M
-4.04%-6.50M
-202.80%-5.50M
์ˆœ์ด์ต
-9.34%-5.48M
-98.81%-7.68M
-143.86%-6.89M
-106.42%-5.40M
-159.74%-5.01M
-2.68%-3.86M
33.62%-2.83M
-24.99%-2.62M
65.09%-1.93M
-120.96%-3.76M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.70M
17.64%-6.09M
0.35%-5.43M
-72.96%-6.99M
-56.83%-5.33M
-18.30%-7.39M
-200.76%-5.45M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
-37.40%4.21M
33.60%4.82M
-41.34%4.38M
-21.80%5.79M
-14.29%6.73M
-0.11%3.61M
203.66%7.47M
272.75%7.40M
46.99%7.85M
-58.56%3.61M
-54.63%2.46M
-79.54%1.98M
-65.56%5.34M
-59.66%8.71M
-80.15%5.42M
-71.49%9.70M
-60.62%15.51M
29.08%21.60M
33.98%27.32M
905.35%34.03M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
217.29%20.39M
281.56%17.94M
263.12%18.08M
45.08%7.44M
-3.27%6.43M
-41.75%4.70M
-31.71%4.98M
-28.48%5.13M
-21.29%6.64M
1.19%8.07M
6.99%7.29M
20.17%7.17M
26.08%8.44M
26.75%7.97M
-9.27%6.81M
-27.22%5.96M
-28.13%6.69M
-13.75%6.29M
-4.01%7.51M
17.14%8.20M
์ด ์ž์‚ฐ
-7.26%24.14M
121.97%25.04M
64.56%25.15M
67.09%25.64M
64.33%26.03M
-4.42%11.28M
42.44%15.28M
48.75%15.35M
15.22%15.84M
-30.97%11.80M
-21.79%10.73M
-43.93%10.32M
-43.59%13.75M
-42.14%17.10M
-59.27%13.72M
-55.15%18.40M
-47.19%24.38M
34.63%29.56M
33.01%33.69M
383.54%41.02M
๋ถ€์ฑ„ ์ด๊ณ„
31.14%28.13M
282.69%26.31M
264.28%26.70M
200.86%23.11M
125.91%21.45M
-38.74%6.88M
-28.97%7.33M
-25.21%7.68M
-18.45%9.49M
11.03%11.22M
15.70%10.32M
20.20%10.27M
22.10%11.64M
18.67%10.11M
9.44%8.92M
-0.12%8.54M
-1.41%9.54M
11.87%8.52M
-3.09%8.15M
0.72%8.56M
์ž๋ณธ ์ด๊ณ„
-186.97%-3.99M
-128.75%-1.27M
-119.49%-1.55M
-66.97%2.53M
-27.79%4.58M
657.22%4.41M
1835.28%7.95M
16563.04%7.67M
201.38%6.35M
-91.68%582.00K
-91.44%411.00K
-99.53%46.00K
-85.81%2.11M
-66.76%6.99M
-81.20%4.80M
-69.65%9.86M
-59.33%14.84M
46.71%21.04M
50.96%25.54M
335698.85%32.47M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
9.90%-3.15M
-58.32%-6.01M
-29.66%-3.81M
0.62%-4.16M
-14.63%-3.49M
-50.87%-3.80M
-6.99%-2.94M
-49.54%-4.19M
-6.61%-3.05M
28.91%-2.52M
8.40%-2.75M
52.07%-2.80M
38.69%-2.86M
41.81%-3.54M
27.22%-3.00M
-43.95%-5.84M
-26.24%-4.66M
-57.53%-6.08M
-13.92%-4.12M
-549.70%-4.06M
์ˆœํˆฌ์ž
92.96%-416.00K
85.25%-18.00K
-858.18%-1.58M
143.23%83.00K
-9743.33%-5.91M
19.21%-122.00K
0.00%-165.00K
-24.68%-192.00K
75.51%-60.00K
47.75%-151.00K
17.50%-165.00K
-54.00%-154.00K
51.39%-245.00K
-140.83%-289.00K
47.69%-200.00K
76.85%-100.00K
67.10%-504.00K
54.15%-120.00K
-301.45%-382.35K
-3498.57%-431.97K
์ˆœ์žฌ๋ฌดํ™œ๋™
-71.83%3.23M
--6.11M
41.94%4.33M
-27.04%2.76M
54.86%11.46M
-100.00%0.00
-14.41%3.05M
--3.79M
--7.40M
-50.58%3.63M
--3.57M
--0.00
--0.00
--7.36M
100.00%0.00
100.00%0.00
-100.00%0.00
100.00%0.00
-100.00%-434.00
-166.18%-1.17M

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Vivos Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 17.44M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 15.03M์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 4.38M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -41.34์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Vivos Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 25.15M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 64.56์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Vivos Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 26.70M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 264.28์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Vivos Therapeutics Inc์˜ ์ด์ž๋ณธ์€ -1.55M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -119.49์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Vivos Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -19.89M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -78.09์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Vivos Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” -7.53M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -1225.00์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Vivos Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 18.56M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 3.82์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -2.06์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 7.11์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -21.17M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -90.10์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -121.71์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -64.28์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 52.93์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -5.71์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -655.01์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -146.01์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -105.01์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -22.65์ž…๋‹ˆ๋‹ค.

Vivos Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Vivos Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -19.89M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -78.09์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ